Concepedia

Publication | Open Access

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

DOIFull Paper Access

445

Citations

14

References

2007

Year

Emanuele Bosi, R. Camisasca, C. Collober, Erika Rochotte, Alan J. Garber
Diabetes Care

Abstract

Vildagliptin is well tolerated and produces clinically meaningful, dose-related decreases in A1C and FPG as add-on therapy in patients with type 2 diabetes inadequately controlled by metformin.

References

YearCitations

Page 1